Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.

By T. Rasmussen, M. Tolstrup, C. Brinkmann, R. Olesen, C. Erikstrup, A. Solomon, Anni Winckelmann, S. Palmer, C. A. Dinarello, M. Buzón and 4 more. The Lancet HIV, 2014

601 citations recorded by the source corpus.

Subfields: Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/66f97907d42fc2ba36f75bfe7d94f87b685dccd9